Plant Comparison

Hawthorn vs Tormentil

A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.

First plant
Second plant
Show:
Plant AHawthornCrataegus monogynaRosaceaeFull monograph →
Plant BTormentilPotentilla erectaRosaceaeFull monograph →

At a glance

Hawthorn and Tormentil: both belong to the Rosaceae family; they share 3 indicated uses (arthritis / joint pain, inflammation (general), skin irritation); 1 pharmacological action in common.

HawthornTormentil
Constituents22
Pharmacological actions43
Indicated uses67
Safety notes22
Cited sources2115
Indicated uses
Only Hawthorn
Cancer (anticancer research)Cardiovascular / heart healthInsomnia / sleeplessness
Shared (3)
Arthritis / joint painInflammation (general)Skin irritation
Only Tormentil
DiarrhoeaInflammatory bowel disease (IBD)Sore throatWounds
Pharmacological actions
Only Hawthorn
Anticancer (preclinical)AntioxidantSedative / sleep support
Shared (1)
Anti-inflammatory
Only Tormentil
AntidiarrhoealAstringent

Evidence face-off — shared uses

ConditionHawthornTormentilVerdict
Arthritis / joint pain1/101/10Comparable evidence
Inflammation (general)1/103/10Stronger for Tormentil
Skin irritation1/106/10Stronger for Tormentil

Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.

Key Constituents

Flavonoids (catechins, quercetin, vitexin) and anthocyanins[1, 4]

Principal cardioprotective and antioxidant polyphenols characterised by chemical profiling of leaf, flower and fruit.

FlavonoidsCatechinsQuercetinAnthocyanins
Oligomeric proanthocyanidins[4]

Contribute to the vasoactive and antioxidant effects, the basis for extract standardisation.

Proanthocyanidins
Tannins (ellagitannins such as agrimoniin, and catechin-type tannins)[14, 15]

The main astringent active constituents.

TanninsCatechins
Flavonoids and phenolic acids[15]

Antioxidant supporting constituents.

Phenolic acidsFlavonoids

Pharmacological Actions

Anti-inflammatory[4, 13, 14, 15]
Anticancer (preclinical)[1]
Antioxidant[4, 5, 6, 9, 10, 11, 12, 13, 14, 15]
Sedative / sleep support[13, 14, 15]
Anti-inflammatory[1, 4, 6, 9, 10, 14, 15]

Anti-inflammatory gargle / mouthwash for sore throat and inflammation of the mouth and throat

Antidiarrhoeal[1, 4, 8, 14, 15]

Astringent for mild diarrhoea (ellagitannins tighten the gut lining) - in a paediatric RCT, tormentil root extract shortened rotavirus diarrhoea (3 vs 5 days) and reduced rehydration needs

Astringent[2, 4, 7, 8, 13, 14, 15]

Astringent for mild diarrhoea (ellagitannins tighten the gut lining) - in a paediatric RCT, tormentil root extract shortened rotavirus diarrhoea (3 vs 5 days) and reduced rehydration needs

Traditional & Indicated Uses

Arthritis / joint pain[13, 14, 15]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Arthritis / joint pain
Cancer (anticancer research)[1]Traditional · 2/10

inferred from anticancer action

Evidence: 2
Label: Cancer (anticancer research)
Cardiovascular / heart health[13, 14, 15]Traditional · 1/10
Evidence: 1
Label: Cardiovascular / heart health
Inflammation (general)[13, 14, 15]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Inflammation (general)
Insomnia / sleeplessness[13, 14, 15]Traditional · 1/10

inferred from sedative action

Evidence: 1
Label: Insomnia / sleeplessness
Skin irritation[13, 14, 15]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Skin irritation
Arthritis / joint pain[14, 15]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Arthritis / joint pain
Diarrhoea[1, 4, 8, 14, 15]Moderate · 5/10

Astringent for mild diarrhoea (ellagitannins tighten the gut lining) - in a paediatric RCT, tormentil root extract shortened rotavirus diarrhoea (3 vs 5 days) and reduced rehydration needs

Evidence: 5
Label: Diarrhoea
Inflammatory bowel disease (IBD)[9, 11, 15]Limited · 3/10

Supportive in inflammatory bowel disease / ulcerative colitis (limited trial evidence)

Evidence: 3
Label: Inflammatory bowel disease (IBD)
Inflammation (general)[4, 10, 14, 15]Limited · 3/10

Anti-inflammatory gargle / mouthwash for sore throat and inflammation of the mouth and throat

Evidence: 3
Label: Inflammation (general)
Skin irritation[6, 8, 10, 14, 15]Moderate · 6/10

inferred from astringent action

Evidence: 6
Label: Skin irritation
Sore throat[7, 13, 14, 15]Traditional · 2/10

Anti-inflammatory gargle / mouthwash for sore throat and inflammation of the mouth and throat

Evidence: 2
Label: Sore throat
Wounds[8, 14, 15]Moderate · 5/10

inferred from astringent action

Evidence: 5
Label: Wounds

Safety, Cautions & Contraindications

Safety note[13, 14, 15]Caution

Generally well tolerated. Hawthorn should not replace prescribed cardiac medications without medical supervision. May potentiate the effects of cardiac glycosides (digoxin), antihypertensive drugs, and coronary dilators. Not recommended during pregnancy and breastfeeding due to insufficient safety data. Mild side effects (nausea, dizziness, GI upset) occasionally reported.

Safety note[13, 14, 15, 16]Caution

Duke (2002) rates hawthorn as +++ — one of the most clinically supported cardiovascular herbs. Clinical evidence (score 2) supports its use for decreasing cardiac output (NYHA functional Stage II heart failure), as recognized by Commission E. Key activities include vasodilation, positive inotropic effects, and antioxidant protection of vascular tissue. Dose: 160–900 mg standardized leaf/flower extract (containing 18.75% oligomeric proanthocyanidins) daily. Duke emphasizes that hawthorn should not replace conventional heart failure therapy, and therapeutic effects may take 4–8 weeks to emerge. Mild interactions with cardiac glycosides (digitalis) are possible (Duke, 2002).

Safety note[14]Info

Tannin-rich: high or prolonged intake may cause stomach upset or constipation and can reduce the absorption of iron and some medicines taken at the same time.

Safety note[14]Caution

Diarrhoea persisting more than 3-4 days, or with fever or blood in the stool, needs medical care. Use in pregnancy and breastfeeding is not recommended in the absence of data.

External Ids

Gbif: 9220780
Wikidata: Q161511
Gbif: 5365576
Wikidata: Q160098

Botanical Description

Small deciduous tree or large shrub, densely thorny, with deeply lobed, glossy leaves (more deeply cut than midland hawthorn). Clusters of small, five-petalled white flowers with a strong, musky scent appear in spring ('May blossom'), followed by small red berries (haws), each containing a single seed (nutlet) - the origin of the species name monogyna.[4]

Height: 5-10 m
Habit: Small deciduous, densely thorny tree or large shrub
Leaves: Deeply lobed, glossy (more deeply cut than C. laevigata)
Flowers: Clusters of small, five-petalled white, strongly musky-scented flowers
Stem: Densely thorny branches; grey, fissured bark on older wood
Root: Deep, spreading root system
Fruit: Small red berry (haw), containing a single seed
Flowering Period: May

Low, sprawling to semi-erect perennial herb (Rosaceae) with wiry stems. Leaves are palmate, typically with 4-5 leaflets and large leaf-like stipules that give the impression of more leaflets. Flowers are small, yellow and four-petalled - unusual among Potentilla species, most of which have five petals. The thick, woody rhizome is reddish inside when cut, the origin of the old name 'bloodroot' for this European species.[14]

Height: Low, sprawling to semi-erect, stems to about 30-45 cm
Habit: Low, sprawling to semi-erect perennial herb
Leaves: Palmate, typically 4-5 leaflets, with large leaf-like stipules
Flowers: Small, yellow, four-petalled (unusual among Potentilla species)
Stem: Wiry, sprawling to semi-erect
Root: Thick, woody rhizome, reddish inside when cut
Fruit: Small dry achenes (typical Rosaceae)
Flowering Period: May-September

Habitat

One of the commonest hedgerow and scrub trees of Europe, growing in hedgerows, woodland edges, scrub and pasture on a wide range of soils; native to Europe, North Africa and Western Asia.[4]

Native to Europe and western Asia, common in acidic grassland, heath, moorland, open woodland and pastures on poor, well-drained soils.[14]

Harvesting

Flowers are picked as they open in May, leaves are picked with the young flowering shoots, and the ripe red berries (haws) are gathered in autumn after the first frosts soften them slightly; all three parts are traditionally combined.[4]

Parts: Flower, Fruit, Leaf
Season: Flower and leaf in May; fruit in autumn

The rhizome is dug in autumn or early spring, when tannin content is highest, then cleaned and dried.[14]

Parts: Rhizome
Season: Autumn or early spring

Traditional Uses

Common hawthorn shares the same long cardiovascular and calming tradition as midland hawthorn, used across European herbal medicine as a heart tonic for mild circulatory complaints, palpitations and nervous tension, and remains one of the most clinically studied cardiovascular botanicals.[4]

Tormentil rhizome has an official European herbal-monograph tradition for mild diarrhoea and inflammation of the mouth and throat, reflecting its long folk use as a powerful astringent for gut and mucous-membrane complaints. Modern trials confirm its ellagitannin-rich rhizome shortens the duration of infectious (rotavirus) diarrhoea.[8, 14, 15]

Preparations

Standardised extract[4]

Leaf-and-flower extract standardised to flavonoid or procyanidin content, taken as tablets or capsules; the best-studied clinical form.

Decoction[14]

Dried rhizome simmered in water, the standard astringent preparation for diarrhoea.

Tincture[15]

Alcoholic extract, taken diluted or used as a gargle/mouthwash.

Gargle/mouthwash[15]

Diluted decoction or tincture used for sore throat and mouth inflammation.

Dosage

Standardised extract[13]

The EU herbal monograph on Crataegus spp., folium cum flore gives dry extracts in divided daily doses of 240-900 mg (single dose 80-450 mg) or, for one quantified extract, 570-1750 mg daily (single dose 190-350 mg), in adults and elderly. If symptoms persist longer than 2 weeks a doctor should be consulted, and hawthorn is never used as a substitute for prescribed heart medication without medical supervision. Educational reference only, not a prescription.

Herbal tea[13]

The EU herbal monograph gives 1-2 g of the comminuted leaf and flower in 150 mL of boiling water as an infusion, up to 4 times daily (maximum 6 g daily), in adults and elderly. Educational reference only, not a prescription.

Decoction/tincture[14, 15]

EMA/ESCOP guidance suggests around 4-6 g dried rhizome (or an equivalent decoction), divided into 2-3 doses daily, for diarrhoea, or a diluted tincture used as a gargle several times daily. Educational reference only, not a prescription.

References

REF-0785, REF-0786, REF-0787, REF-1709, REF-1710, REF-1711, REF-1712, REF-1713, REF-1714, REF-1715, REF-1716, REF-1717
REF-0970, REF-0971, REF-0972, REF-0973, REF-0974, REF-0975, REF-0976, REF-0602, REF-0977, REF-0978, REF-2592, REF-2593, REF-2594

Drug Class Interactions

Safety note[17, 18, 19]Caution
Drug Class: cardiac-glycosides
Mechanism: Hawthorn has its own positive effect on the heart (a Cochrane review found it improves heart-failure symptoms and exercise tolerance) and shares P-glycoprotein handling with digoxin, so combining it with digoxin or other cardiac-glycoside heart drugs should be supervised even though a controlled study found no major change in digoxin levels.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
Safety note[18, 19]Caution
Drug Class: antihypertensives
Mechanism: Hawthorn can mildly lower blood pressure and reduce cardiac oxygen demand (a Cochrane meta-analysis found a lower pressure-heart-rate product), which may add to the effect of blood-pressure and heart-failure medicines.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
Safety note[20, 21]Caution
Drug Class: sedatives-cns-depressants
Mechanism: Hawthorn is traditionally used as a calming, sedative herb; taken with sedatives, sleeping tablets or other central-nervous-system depressants (including alcohol) it may add to drowsiness and slowed reactions.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03

Not documented

Lookalikes Review

Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07
Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07

References & Sources

  1. Ez-Zahra Amrati, F., Mssillou, I., Boukhira, S., Djiddi Bichara, M. et al (2024) 'Phenolic Composition of Crataegus monogyna Jacq. Extract and Its Anti-Inflammatory, Hepatoprotective, and Antileukemia Effects', Pharmaceuticals (Basel), 17(6), pp. 786. doi:10.3390/ph17060786 Preclinical
    https://doi.org/10.3390/ph17060786
  2. Lis, M., Szczypka, M., Suszko-Pawłowska, A., Sokół-Łętowska, A. et al (2019) 'Hawthorn (Crataegus monogyna) Phenolic Extract Modulates Lymphocyte Subsets and Humoral Immune Response in Mice', Planta Medica, 86(2), pp. 160-168. doi:10.1055/a-1045-5437 Preclinical
    https://doi.org/10.1055/a-1045-5437
  3. Paun, G., Neagu, E., Albu, C., Alecu, A. et al (2024) 'Antioxidant and Antidiabetic Activity of Crataegus monogyna L. and Cornus mas Fruit Extracts', Molecules, 29(15), pp. 3595. doi:10.3390/molecules29153595 Preclinical
    https://doi.org/10.3390/molecules29153595
  4. Nabavi, S.F., Habtemariam, S., Ahmed, T., Sureda, A., Daglia, M. and Sobarzo-Sanchez, E (2015) 'Polyphenolic Composition of Crataegus monogyna Jacq.: From Chemistry to Medical Applications', Nutrients, 7(9), pp. 7708-7728. doi:10.3390/nu7095361 Meta-analysis / review
    https://doi.org/10.3390/nu7095361
  5. Belabdelli, F., Bekhti, N., Piras, A., Benhafsa, F.M., Ilham, M. and Adil, S (2021) 'Chemical composition, antioxidant and antibacterial activity of Crataegus monogyna leaves' extracts', Natural Product Research, 36(12), pp. 3234-3239. doi:10.1080/14786419.2021.1958215 Preclinical
    https://doi.org/10.1080/14786419.2021.1958215
  6. Jalali, A.S., Hasanzadeh, S. and Malekinejad, H (2012) 'Crataegus monogyna aqueous extract ameliorates cyclophosphamide-induced toxicity in rat testis: stereological evidences', Acta Medica Iranica, 50(1), pp. 1-8. Preclinical
    https://scholar.google.com/scholar?q=Crataegus%20monogyna%20aqueous%20extract%20ameliorates%20cyclophosphamide-induced%20toxicity%20in%20rat%20testis%3A%20stereological%20evidences
  7. Martin-Garcia, B., Razola-Diaz, M.D.C., Gomez-Caravaca, A.M., Benitez, G. and Verardo, V (2021) 'Setup of an Ultrasonic-Assisted Extraction to Obtain High Phenolic Recovery in Crataegus monogyna Leaves', Molecules, 26(15), pp. 4536. doi:10.3390/molecules26154536 Preclinical
    https://doi.org/10.3390/molecules26154536
  8. Arslan, R., Bektas, N., Bor, Z. and Sener, E (2014) 'Evaluation of the antithrombotic effects of Crataegus monogyna and Crataegus davisii in the carrageenan-induced tail thrombosis model', Pharmaceutical Biology, 53(2), pp. 275-279. doi:10.3109/13880209.2014.914957 Preclinical
    https://doi.org/10.3109/13880209.2014.914957
  9. Edwards, J.E., Brown, P.N., Talent, N., Dickinson, T.A. and Shipley, P.R (2012) 'A review of the chemistry of the genus Crataegus', Phytochemistry, 79, pp. 5-26. doi:10.1016/j.phytochem.2012.04.006 Meta-analysis / review
    https://doi.org/10.1016/j.phytochem.2012.04.006
  10. Jarzycka, A., Lewinska, A., Gancarz, R. and Wilk, K.A (2013) 'Assessment of extracts of Helichrysum arenarium, Crataegus monogyna, Sambucus nigra in photoprotective UVA and UVB; photostability in cosmetic emulsions', Journal of Photochemistry and Photobiology B: Biology, 128, pp. 50-57. doi:10.1016/j.jphotobiol.2013.07.029 Preclinical
    https://doi.org/10.1016/j.jphotobiol.2013.07.029
  11. Lucconi, G., Chlapanidas, T., Martino, E., Gaggeri, R., Perteghella, S. and Rossi, D (2013) 'Formulation of microspheres containing Crataegus monogyna Jacq. extract with free radical scavenging activity', Pharmaceutical Development and Technology, 19(1), pp. 65-72. doi:10.3109/10837450.2012.752387 Preclinical
    https://doi.org/10.3109/10837450.2012.752387
  12. Zorniak, M., Szydlo, B. and Krzeminski, T.F (2017) 'Crataegus special extract WS 1442: up-to-date review of experimental and clinical experiences', Journal of Physiology and Pharmacology, 68(4), pp. 521-526. Meta-analysis / review
    https://scholar.google.com/scholar?q=Crataegus%20special%20extract%20WS%201442%3A%20up-to-date%20review%20of%20experimental%20and%20clinical%20experiences
  13. European Medicines Agency (2016) 'European Union herbal monograph on Crataegus spp., folium cum flore'. Traditional / reference
    https://scholar.google.com/scholar?q=European%20Union%20herbal%20monograph%20on%20Crataegus%20spp.%2C%20folium%20cum%20flore
  14. Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure'. Traditional / reference
    https://scholar.google.com/scholar?q=Hawthorn%20extract%20for%20treating%20chronic%20heart%20failure
  15. Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
    https://powo.science.kew.org
  16. Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
    https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
  17. Tankanow, R., Tamer, H.R., Streetman, D.S., Smith, S.G., Welton, J.L., Annesley, T., Aaronson, K.D. and Bleske, B.E (2003) 'Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha)', Journal of Clinical Pharmacology, 43(6), pp. 637-642. doi:10.1177/0091270003253417 Randomized trial
    https://doi.org/10.1177/0091270003253417
  18. Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure', Cochrane Database of Systematic Reviews, 2008(1), pp. CD005312. doi:10.1002/14651858.CD005312.pub2 Meta-analysis / review
    https://doi.org/10.1002/14651858.CD005312.pub2
  19. Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure', Cochrane Database of Systematic Reviews, 2008(1), pp. CD005312. doi:10.1002/14651858.CD005312.pub2 Meta-analysis / review
    https://doi.org/10.1002/14651858.CD005312.pub2
  20. Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
    https://doi.org/10.1002/ptr.8201
  21. Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
    https://doi.org/10.1177/1534735404265003
  1. Bandick, R., Busmann, L.V., Mousavi, S., Shayya, N.W. and others (2023) 'Therapeutic Effects of Oral Application of Menthol and Extracts from Tormentil (Potentilla erecta), Raspberry Leaves and Loosestrife during Acute Murine Campylobacteriosis', Pharmaceutics, 15(10), pp. 2410. doi:10.3390/pharmaceutics15102410 Preclinical
    https://doi.org/10.3390/pharmaceutics15102410
  2. Fecka, I., Kucharska, A.Z. and Kowalczyk, A (2015) 'Quantification of tannins and related polyphenols in commercial products of tormentil (Potentilla tormentilla)', Phytochemical Analysis, 26(5), pp. 353-366. doi:10.1002/pca.2570 Preclinical
    https://doi.org/10.1002/pca.2570
  3. Marcinczyk, N., Jarmoc, D., Leszczynska, A., Zakrzeska, A. and others (2017) 'Antithrombotic Potential of Tormentil Extract in Animal Models', Frontiers in Pharmacology, 8, pp. 534. doi:10.3389/fphar.2017.00534 Preclinical
    https://doi.org/10.3389/fphar.2017.00534
  4. Melzig, M.F. and Bottger, S (2020) 'Tormentillae rhizoma - Review for an Underestimated European Herbal Drug', Planta Medica, 86(15), pp. 1050-1057. doi:10.1055/a-1129-7214 Traditional / reference
    https://doi.org/10.1055/a-1129-7214
  5. Marcinczyk, N., Golaszewska, A., Gromotowicz-Poplawska, A., Misztal, T. and others (2021) 'Multidirectional Effects of Tormentil Extract on Hemostasis in Experimental Diabetes', Frontiers in Pharmacology, 12, pp. 682987. doi:10.3389/fphar.2021.682987 Preclinical
    https://doi.org/10.3389/fphar.2021.682987
  6. Hoffmann, J., Gendrisch, F., Schempp, C.M. and Wolfle, U (2020) 'New Herbal Biomedicines for the Topical Treatment of Dermatological Disorders', Biomedicines, 8(2), pp. 27. doi:10.3390/biomedicines8020027 Traditional / reference
    https://doi.org/10.3390/biomedicines8020027
  7. Tomczyk, M., Sosnowska, K., Pleszczynska, M., Strawa, J. and others (2017) 'Hydrogel Containing an Extract of Tormentillae rhizoma for the Treatment of Biofilm-Related Oral Diseases', Natural Product Communications, 12(3), pp. 417-421. doi:10.1177/1934578x1701200328 Preclinical
    https://doi.org/10.1177/1934578x1701200328
  8. Subbotina, M.D., Timchenko, V.N., Vorobyov, M.M., Konunova, Y.S., Aleksandrovih, Y.S. and Shushunov, S (2003) 'Effect of oral administration of tormentil root extract (Potentilla tormentilla) on rotavirus diarrhea in children: a randomized, double blind, controlled trial', The Pediatric Infectious Disease Journal, 22(8), pp. 706--711. doi:10.1097/01.inf.0000078355.29647.d0 Randomized trial
    https://doi.org/10.1097/01.inf.0000078355.29647.d0
  9. Wan, P., Chen, H., Guo, Y. and Bai, A.P (2014) 'Advances in treatment of ulcerative colitis with herbs: from bench to bedside', World Journal of Gastroenterology, 20(39), pp. 14099-14104. doi:10.3748/wjg.v20.i39.14099 Traditional / reference
    https://doi.org/10.3748/wjg.v20.i39.14099
  10. Wolfle, U., Hoffmann, J., Haarhaus, B., Rao Mittapalli, V. and Schempp, C.M (2017) 'Anti-inflammatory and vasoconstrictive properties of Potentilla erecta - A traditional medicinal plant from the northern hemisphere', Journal of Ethnopharmacology, 204, pp. 86-94. doi:10.1016/j.jep.2017.03.058 Clinical study
    https://doi.org/10.1016/j.jep.2017.03.058
  11. Moss, A.C. and Cheifetz, A.S (2007) 'Reducing the torment of diarrhea: tormentil for active ulcerative colitis', Journal of Clinical Gastroenterology, 41(9), pp. 797-798. doi:10.1097/MCG.0b013e3180684255 Clinical study
    https://doi.org/10.1097/MCG.0b013e3180684255
  12. Shushunov, S., Balashov, L., Kravtsova, A., Krasnogorsky, I., Latte, K.P. and Vasiliev, A (2009) 'Determination of acute toxicity of the aqueous extract of Potentilla erecta (Tormentil) rhizomes in rats and mice', Journal of Medicinal Food, 12(5), pp. 1173-1176. doi:10.1089/jmf.2008.0281 Preclinical
    https://doi.org/10.1089/jmf.2008.0281
  13. Kirsch, J., Jung, A., Hille, K., Konig, B., Hannig, C., Kolling-Speer, I., Speer, K. and Hannig, M (2020) 'Effect of fragaria vesca, hamamelis and tormentil on the initial bacterial colonization in situ', Archives of Oral Biology, 118, pp. 104853. doi:10.1016/j.archoralbio.2020.104853 Preclinical
    https://doi.org/10.1016/j.archoralbio.2020.104853
  14. European Medicines Agency (HMPC) (n.d.) 'European Union herbal monograph on Potentilla erecta (L.) Raeusch., rhizoma (Tormentillae rhizoma)'. Available at: https://www.ema.europa.eu/en/medicines/herbal/tormentillae-rhizoma Traditional / reference
    https://www.ema.europa.eu/en/medicines/herbal/tormentillae-rhizoma
  15. ESCOP (European Scientific Cooperative on Phytotherapy) (n.d.) 'Tormentillae rhizoma (Tormentil) monograph', pp. com. Available at: https://www.escop.com/downloads/tormentil/ Traditional / reference
    https://www.escop.com/downloads/tormentil/

Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.